Display options
Cite
Dilsizian V. Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow. J Nucl Cardiol. 2021;28(2):723-728doi: 10.1007/s12350-020-02492-8.
Dilsizian, V. (2021). Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 28(2), 723-728. https://doi.org/10.1007/s12350-020-02492-8
Dilsizian, Vasken. "Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 28,2 (2021): 723-728. doi: https://doi.org/10.1007/s12350-020-02492-8
Dilsizian V. Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow. J Nucl Cardiol. 2021 Apr;28(2):723-728. doi: 10.1007/s12350-020-02492-8. Epub 2021 Jan 07. PMID: 33415645.
Copy Download .nbib Format: NLM
Share it on

J Nucl Cardiol. 2021 Apr;28(2):723-728. doi: 10.1007/s12350-020-02492-8. Epub 2021 Jan 07.

Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Vasken Dilsizian

Affiliations

  1. Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD, 21201, USA. [email protected].

PMID: 33415645 DOI: 10.1007/s12350-020-02492-8

[No abstract available.]

References

  1. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977;55:294-302. - PubMed
  2. Akins CW, Pohost GM, Desanctis RW, Block PC. Selection of angina-free patients with severe left ventricular dysfunction for myocardial revascularization. Am J Cardiol 1980;46:695-700. - PubMed
  3. Dilsizian V, Bonow RO, Cannon RO, et al. The effect of coronary artery bypass grafting on left ventricular systolic function at rest: Evidence for preoperative subclinical myocardial ischemia. Am J Cardiol 1988;61:1248-54. - PubMed
  4. Berman M, Fischman AJ, Southern J, et al. Myocardial adaptation during and after sustained, demand-induced ischemia: Observations in closed-chest, domestic swine. Circulation 1996;94:755-62. - PubMed
  5. Gewirtz H, Dilsizian V. Myocardial viability: Survival mechanisms and molecular imaging targets in acute and chronic ischemia. Circ Res 2017;120:1197-212. - PubMed
  6. Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: Are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 1998;98:501-8. - PubMed
  7. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects: Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85:627-34. - PubMed
  8. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6. - PubMed
  9. Zimmermann R, Mall G, Rauch B, et al. Residual Tl-201 activity in irreversible defects as a marker of myocardial viability: Clinicopathological study. Circulation 1995;91:1016-21. - PubMed
  10. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892-8. - PubMed
  11. Dilsizian V. Cardiac magnetic resonance versus SPECT: Are all noninfarct myocardial regions created equal? J Nucl Cardiol 2007;14(1):9-14. - PubMed
  12. Dilsizian V, Narula J. Qualitative and quantitative scrutiny by regulatory process: Is the truth subjective or objective? J Am Coll Cardiol Imaging 2009;2:1037-8. - PubMed
  13. Dilsizian V. Transition from SPECT to PET myocardial perfusion imaging: A desirable change in nuclear cardiology to approach perfection. J Nucl Cardiol 2016;23:337-8. - PubMed
  14. Dilsizian V, Bacharach SL, Beanlands SR, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert H, Travin M. ASNC Imaging Guidelines/SNMMI Procedure Standard for Positron Emission Tomography (PET) Nuclear Cardiology Procedures. J Nucl Cardiol 2016;23(5):1187-226. - PubMed
  15. Gewirtz H, Dilsizian V. Integration of quantitative PET absolute myocardial blood flow in the clinical management of coronary artery disease. Circulation 2016;133:2180-96. - PubMed
  16. Nesterov SV, Deshayes E, Sciagrà R, et al. Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study. J Am Coll Cardiol Imaging 2014;7:1119-27. - PubMed
  17. Dilsizian V, Chandrashekhar Y, Narula J. Quantitative PET myocardial blood flow: “Trust, but verify”. J Am Coll Cardiol Imaging 2017;10(5):609-10. - PubMed
  18. Danad I, Raijmakers PG, Harms HJ, et al. Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H - PubMed
  19. Dilsizian V, Taillefer R. Journey in evolution of nuclear cardiology: Will there be another quantum leap with the F-18 labeled myocardial perfusion tracers? J Am Coll Cardiol Imaging 2012;5:1269-84. - PubMed

Publication Types